UnitedHealth Group Incorporated (UNH)
Why Raymond James Says Wall Street Is Underestimating UnitedHealth's Earnings Power
Raymond James upgraded UnitedHealth Group (NYSE:UNH) to Outperform from Market Perform on Wednesday, setting a $330 price target.
Wall Street sets UNH stock price target
UnitedHealth Group (NYSE: UNH) received a boost on Wednesday, April 1, when Raymond James upgraded the stock from “Market Perform” to “Outperform,” with a $330 price target.
Warren Buffett has lost over $265 million on historic UnitedHealth stock bet
UnitedHealth (NYSE: UNH) stock has plunged all the way back below the level at which Warren Buffett's Berkshire Hathaway (NYSE: BRK.B), established its 2025 position.
UnitedHealth Group (UNH) Declines More Than Market: Some Information for Investors
UnitedHealth Group (UNH) reached $259.02 at the closing of the latest trading day, reflecting a -3.37% change compared to its last close.
Can UnitedHealth's Avery Redefine Healthcare Navigation at Scale?
UNH rolls out Avery, a generative AI assistant to simplify healthcare navigation, aiming to boost engagement, cut friction and scale across millions.
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street's Bullish Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
The Upside Debate: UnitedHealth's Consistency vs. Centene's Comeback
UNH's steady execution and diversified model face off against CNC's turnaround bid as cost pressures and policy shifts reshape upside potential.
UnitedHealth Group: Fears Remain Overblown In A Panicky Market
UnitedHealth remains a Buy, with shares now trading at a 21% discount to fair value after a recent pullback. UNH's strategy—AI-driven efficiencies, exiting unprofitable markets, and value-based care—positions it for EPS growth despite a modest 2026 revenue decline. Guidance calls for at least $17.75 adjusted diluted EPS in 2026 (8.6% growth), with a 3.1% forward yield and strong dividend safety.
UnitedHealth Group (UNH) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $280.44, denoting a -1.37% move from the preceding trading day.
UnitedHealth, Hims & Hers, Gambling.Com - Value Investing With Raul Shah
Raul Shah from DocShah Financial shares his bullishness on top holdings, Hims & Hers (HIMS), UnitedHealth (UNH), and Gambling.com (GAMB). Tax gain harvesting and more tax takeaways for investors.
UNH Expands Doulas: Better Outcomes or Margin Play Ahead?
UnitedHealth Group rolls out nationwide doula coverage, targeting better maternal outcomes and lower costs through preventive, value-based care.
